IBC
Bacteriophage Therapy: A Promising Solution to Antibiotic Resistance
Get to know about one possible solution to antibiotic resistance: bacteriophages: viruses that infect bacteria.
Adapting to the Evolving Era of Oncology: Implications and Strategies for Research Institutions
Explore key implications, regulatory challenges, and strategies for research institutions to thrive in today’s rapidly evolving oncology landscape.
Decentralized Clinical Trials Involving Biologics: Unique Challenges
Find out what FDA says about decentralized clinical trials and biologics, and what this means in practice.
Diversity, Equity, and Inclusion in Clinical Research
Achieving diversity, equity, and inclusion in clinical trials is vital for inclusive data, safe treatments, and addressing community-specific needs.
Preparing Your Action Plan for the FDA sIRB Mandate
Join our webinar for practical guidance from IRB thought leaders on what to include in your sIRB reliance preparations.
Conducting Research With CAR T Cells
This white paper is a guide for research professionals looking to conduct CAR T cell studies for the first time, as well as for those seeking to expand their existing portfolio.
The Importance of Hazard Communications in Clinical Trials Involving Genetic Engineering
A formal hazard communication or IBC SOP is critical to ensure clinical personnel understand the risks involved with genetically engineered investigational products.
Sponsors: Are Your Sites Ready for an FDA Inspection?
Learn a comprehensive overview to prepare sponsors and sites for an FDA inspection.
mRNA Cancer Vaccines and Therapies: An Overview
Learn about mRNA’s potential impact on cancer research, the technology’s unique challenges, and strategies for researchers developing mRNA-based cancer studies.
Trend Report: DE&I in Clinical Research: Where we are Today
How is the research community addressing recent regulatory actions urging improved diversity and representation in clinical trials?
How Gene Therapy Will Move Rare Disease Research at Warp Speed
There is great potential for research surrounding rare diseases. Uncover various types of gene delivery and its impact on diverse populations in the U.S.
Leading CRO Accelerates Startup with Integrated, Centralized IRB/IBC Reviews
Advarra’s integrated central IRB and IBC review services helped Parexel accelerate the delivery of life-saving and innovative gene therapies.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.